Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 3
1987 1
1989 3
1990 1
1991 1
1994 2
1995 2
1996 3
1998 1
1999 4
2000 8
2001 11
2002 8
2003 4
2004 8
2005 19
2006 12
2007 15
2008 16
2009 17
2010 18
2011 15
2012 21
2013 20
2014 24
2015 22
2016 17
2017 18
2018 12
2019 16
2020 18
2021 20
2022 17
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
The cuprizone model for demyelination.
Torkildsen O, Brunborg LA, Myhr KM, Bø L. Torkildsen O, et al. Among authors: myhr km. Acta Neurol Scand Suppl. 2008;188:72-6. doi: 10.1111/j.1600-0404.2008.01036.x. Acta Neurol Scand Suppl. 2008. PMID: 18439226 Review.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
International Multiple Sclerosis Genetics Consortium (IMSGC); Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC); Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofont… See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium (IMSGC), et al. Among authors: myhr km. Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29. Nat Genet. 2013. PMID: 24076602 Free PMC article.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubo… See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium, et al. Among authors: myhr km. Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251. Nature. 2011. PMID: 21833088 Free PMC article.
Progressive multifocal leukoencephalopathy.
Alstadhaug KB, Myhr KM, Rinaldo CH. Alstadhaug KB, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 2017 Dec 12;137(23-24). doi: 10.4045/tidsskr.16.1092. Print 2017 Dec 12. Tidsskr Nor Laegeforen. 2017. PMID: 29231623 Free article. Review. English, Norwegian.
[Neuromyelitis optica].
Kvistad SA, Wergeland S, Torkildsen Ø, Myhr KM, Vedeler CA. Kvistad SA, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 2013 Oct 15;133(19):2057-61. doi: 10.4045/tidsskr.13.0608. Tidsskr Nor Laegeforen. 2013. PMID: 24129537 Free article. Review. Norwegian.
Break-out session highlights.
Myhr KM, Mäurer M, Ginés MM, Esposito F, Linker R. Myhr KM, et al. Neurodegener Dis Manag. 2017 Nov;7(6s):45-49. doi: 10.2217/nmt-2017-0042. Neurodegener Dis Manag. 2017. PMID: 29143586
Benign multiple sclerosis.
Glad S, Nyland H, Myhr KM. Glad S, et al. Among authors: myhr km. Acta Neurol Scand Suppl. 2006;183:55-7. doi: 10.1111/j.1600-0404.2006.00617.x. Acta Neurol Scand Suppl. 2006. PMID: 16637931 Review.
[Multiple sclerosis].
Nyland H, Myhr KM. Nyland H, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 1995 Jun 30;115(17):2072-7. Tidsskr Nor Laegeforen. 1995. PMID: 7544032 Free article. Review. Norwegian.
Antiviral therapy with tenofovir in MS.
Torkildsen Ø, Myhr KM, Brugger-Synnes P, Bjørnevik K. Torkildsen Ø, et al. Among authors: myhr km. Mult Scler Relat Disord. 2024 Mar;83:105436. doi: 10.1016/j.msard.2024.105436. Epub 2024 Jan 7. Mult Scler Relat Disord. 2024. PMID: 38217968
346 results